EVM16 Injection as a Single and Combination With Tislelizumab in Solid Tumors
EVM16 Injection as a Single and Combination With Tislelizumab in Solid Tumors
Recruiting · NCT06541639 · Registry updated 2026-06-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| EVM16 Injection as a Single and Combination With Tislelizumab in Solid Tumors | Advanced or Recurrent Solid Tumors | Recruiting | Phase 1 | 2026-06-22 | NCT06541639 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Everest Medicines (China) Co.,Ltd. | 4 |
| Peking University | 124 |
| Shanghai Cancer Centre | 4 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Cancer Hospital | Beijing | China | 208 |
| Fudan University Shanghai Cancer Center | Shanghai | China | 1 |